Tawi, Romelyn .
HRN: 22-40-07 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/31/2022
CEFUROXIME 1.5GM (VIAL)
12/31/2022
01/06/2023
İVT
500mg
Q8
Urti
Waiting Final Action
Indication: Prophylaxis Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes